Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Remote PCI: Corindus Explores Performing Cardiac Caths From Miles Away With Robotics

This article was originally published in The Gray Sheet

Executive Summary

Corindus Vascular Robotics, Sanford Health and Helmsley Charitable Trust are partnering on a study of remote robotic-assisted PCI for patients in rural areas.

You may also be interested in...



FDA Expands CorPath Robotic System Labeling To Radial PCIs

The company says as radial percutaneous coronary interventions continue to grow, FDA's 510(k) clearance gives more radiologists and interventional cardiologists access to a system that reduces their exposure to radiation.

Research Briefs: Robotic And Laparoscopic Prostatectomy Prove Safe; CorPath Announces Post-Market Study Of Robot PCI System

Minimally invasive prostatectomy compares favorably to open surgery in analysis of contemporary practice data. Corindus launches post-market registry of CorPath 200 coronary intervention system

New Directions for Robotic Surgery

Medical robotics has changed dramatically since the 1980s, when neurosurgeons first used a robot to precisely hold a fixture during brain surgery. Advances in computer image processing, surgical imaging technologies, techniques for registering surgical images, modeling, mechatronics, surgical simulation, and human-robot interaction have opened the door for emerging technologies that will have an increasing impact on growth in this market for many years to come.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel